Related references
Note: Only part of the references are listed.Perspectives on Tuberculosis Pathogenesis and Discovery of Anti-Tubercular Drugs
Fidele Ntie-Kang et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Trends in discovery of new drugs for tuberculosis therapy
Giovanna Riccardi et al.
JOURNAL OF ANTIBIOTICS (2014)
Delamanid: A new armor in combating drug-resistant tuberculosis
Alphienes Stanley Xavier et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2014)
Characterizing Amosamine Biosynthesis in Amicetin Reveals AmiG as a Reversible Retaining Glycosyltransferase
Ruidong Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
CURRENT CONCEPTS Tuberculosis
Alimuddin Zumla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905
Nobuhiro Koyama et al.
JOURNAL OF ANTIBIOTICS (2010)
NMR structure of the peptidyl transferase RNA inhibitor antibiotic amicetin
Christos Shammas et al.
MAGNETIC RESONANCE IN CHEMISTRY (2007)
Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments
TJ Mincer et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2002)
Mycobacterium smegmatis:: an absurd model for tuberculosis?
JM Reyrat et al.
TRENDS IN MICROBIOLOGY (2001)
Share Paper
